Genotype plays role in schizophrenia response to folate

From Clinical Psychiatry News, 19 March 2013: Folate and vitamin B12 supplements may improve the negative symptoms of schizophrenia but only in patients with a genetic variant that influences folate metabolism, a study has shown. “Although four such variants have previously been associated with negative symptom severity, the genotype that contributed most strongly to treatment Continue reading Genotype plays role in schizophrenia response to folate